The Effect of EMST (Expiratory Muscle Strength Training) Treatment on Swallowing Function in OSAS (Obstructive Sleep Apnea Syndrome)
Project no. 89 · Status: Kapanmış · 2017
Summary
Objective: Swallowing disorders are also seen in patients with Obstructive Sleep Ap-nea Syndrome (OSAS). The aim of this study is to investigate the effect of EMST treatment on swallowing function in severe or moderate OSAS patients. Methods: Fifty-four patients who were diagnosed with severe and moderate Obstruc-tive Sleep Apnea Syndrome in the Department of Chest Diseases of Ege University School of Medicine and started CPAP treatment were included in this study. Thirty patients with impaired swallowing functions (EMST-treated study group n = 15 pa-tients and control group n = 15 patients) were included.Sociodemographic data of the patients, clinical findings related to OSAS (apnea, hypopnea, AHI index ... etc) and swallowing dysfunction were recorded. The patients were re-evaluated at the end of 2 months of EMST treatment. Results: No significant difference was observed between the pre-treatment sociode-mographic data, initial symptoms, FEES findings, and polysomnography test results of both groups and two homogeneous groups were formed (p> 0.05). No statistically significant difference was observed between the two groups in terms of FOSS, FOIS score and symptoms related to swallowing before and after treatment (p> 0.05). EAT-10 Score was found significantly better in the study group after two months of EMST treatment (p <0.05). According to the Yale Pharyngeal Residue Severity Scale, in the study group, significantly less residue was observed in the vallecula with 10,20 ml of water and fish crackers with the assessment of FEES (p <0.05). Conclusions:There is no study that investigates the effects of EMST treatment on swallowing function in OSAS patients with swallowing disorders. In our study, a sig-nificant improvement was observed in the severity of residue and EAT-10 score with EMST treatment in OSAS patients using CPAP (p <0.05).